FIELD: medicine.
SUBSTANCE: method involves correcting the pro- and antioxidant systems by prescribing the preparation Cytoflavin and performing a local exposure generated by Ultratone apparatus with the following parameters: output voltage 3.0 kV, sine-wave output voltage frequency 22 kHz. Cytoflavin is supposed to administer twice a day - in the morning and evening, not later than 5 p.m., at 8-10 hours intervals, at least 30 min before a meal, swallowing it whole and washing down with water, in a standard dosage of 760 mg; the first administration is suggested 3-4 hours before a daily session of the Ultratone therapy in a mode of 22 kHz at a distance from the affected area of 1-2 mm through a gauze wipe for 10-20 seconds per 1 cm2 of the affected area; the above treatment is accompanied with administering prednisolone in an average daily dose of 30 mg daily; repeated therapeutic courses are prescribed for indications 25-30 days later.
EFFECT: method enables reducing lengths of the systemic and local corticosteroid therapy regimens with reducing length of treatment, achieving longer remission, eliminating aesthetic defects, and improving patient's quality of life.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING MICROBIAL ECZEMA | 2018 |
|
RU2699655C1 |
METHOD OF LICHEN PLANUS TREATING | 2016 |
|
RU2627456C1 |
METHOD FOR TREATING ONYCHOMYCOSIS OF FEET | 2018 |
|
RU2698454C1 |
METHOD OF TREATING ECZEMA | 2014 |
|
RU2576834C2 |
METHOD FOR TREATING THE CASES OF SCLERODERMA SYSTEMATICA | 2002 |
|
RU2289441C2 |
METHOD OF TREATMENT OF CHRONIC STAPHYLODERMA | 1993 |
|
RU2065748C1 |
METHOD FOR TREATMENT OF SKIN MANIFESTATIONS OF A SCLERODERMA | 2016 |
|
RU2657812C2 |
METHOD OF TREATING MORPHEA | 2010 |
|
RU2424008C1 |
METHOD FOR TREATING LOCALIZED SCLERODERMA | 2004 |
|
RU2264815C2 |
METHOD FOR TREATMENT OF EARLY STAGES OF OSTEONECROSIS OF FEMORAL HEAD | 2022 |
|
RU2792548C1 |
Authors
Dates
2016-01-27—Published
2014-12-03—Filed